Srivandana Akshintala

4PUBLICATIONS
34CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 27, 2025
Phase II study of axitinib in patients with NF2-related schwannomatosis and progressive vestibular schwannomas.

Mekka R Garcia, Mari Hagiwara, Anna Yaffe

|Oct 16, 2024
Tumor Volume Doubling Time of Less Than 1 Year Is Associated With a Higher Risk of Death From Medullary Thyroid Cancer.

Noha Behairy, Anthony J Leonardi, Sriram Gubbi

|Jul 03, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.

Srivandana Akshintala, R Taylor Sundby, Donna Bernstein

Pageof 1